Iht Wealth Management, LLC Galectin Therapeutics Inc Transaction History

Iht Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 19, 2020	SELL	$2.53 - $3.64 $71,232 - $102,484	-28,155 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.66 - $3.15 $16,600 - $31,500	10,000 Added 55.08%	28,155 $86,000
Q3 2019 Nov 15, 2019	BUY	$3.0 - $4.05 $6,225 - $8,403	2,075 Added 12.9%	18,155 $67,000
Q1 2019 May 16, 2019	BUY	$3.86 - $6.02 $21,423 - $33,411	5,550 Added 52.71%	16,080 $82,000
Q4 2018 Feb 15, 2019	BUY	$3.43 - $5.74 $1,715 - $2,870	500 Added 4.99%	10,530 $36,000
Q3 2018 Nov 14, 2018	BUY	$3.68 - $6.93 $36,910 - $69,507	10,030 New	10,030 $60,000
Q2 2018 Aug 13, 2018	SELL	$3.16 - $9.16 $21,424 - $62,104	-6,780 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.54 - $3.34 $4,281 - $9,285	2,780 Added 69.5%	6,780 $34,000
Q3 2017 Nov 14, 2017	BUY	$1.67 - $2.3 $6,680 - $9,200	4,000	4,000 $10,000

9.69M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $73.7M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.